AGNISTA
DEAD

Serial Number

90311132

Owner

Agnista Therapeutics Inc.

Attorney

Cassandra M. Tam

Filing Date

Nov 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

AGNISTA Trademark

Serial Number: 90311132

AGNISTA is a trademark filed by Agnista Therapeutics Inc. on November 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

Agnista Therapeutics Inc. (2 trademarks)

455 Margarita Ave
Palo Alto, CA 94306

Entity Type: 03

Trademark Details

Filing Date

November 10, 2020

Registration Date

Not Registered

Published for Opposition

May 25, 2021

Goods & Services

Biological preparations for the treatment of cancer; Biological preparations for the treatment of inflammatory diseases, disorders and conditions; Biological preparations for the treatment of immune related diseases, disorders and conditions; Pharmaceutical preparations for the treatment of immune related diseases, disorders and conditions; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of inflammatory diseases, disorders and conditions

Licensing of intellectual property; Licensing of intellectual property in the field of pharmaceuticals; Licensing of intellectual property in the field of medical and scientific technologies

Clinical research in the field of immune related diseases, disorders and conditions; Clinical research in the field of tumors, malignancies, and related diseases, disorders and conditions; Clinical research in the field of inflammatory diseases, disorders and conditions; Development of pharmaceutical preparations and medicines; Medical research; Medical and scientific research in the field of inflammatory diseases and cancer treatment and diagnosis; Medical and scientific research in the field of immune related diseases, disorders and conditions; Medical and scientific research in the field of tumors, malignancies, and related diseases, disorders and conditions; Pharmaceutical products development; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 22, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 21, 2022 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 20, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 25, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 25, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 5, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2021 CNSA
ASSIGNED TO EXAMINER
Apr 17, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2021 NWOS
NEW APPLICATION ENTERED
Nov 13, 2020 NWAP